David Capper Selected Research

gonadotropin releasing hormone associated peptide

5/2021

High-grade astrocytoma with piloid features (HGAP): the Charité experience with a new central nervous system tumor entity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Capper Research Topics

Disease

92	Neoplasms (Cancer) 10/2022 - 02/2006
35	Glioma (Gliomas) 12/2021 - 05/2007
30	Glioblastoma (Glioblastoma Multiforme) 04/2021 - 02/2008
26	Astrocytoma (Pilocytic Astrocytoma) 05/2021 - 02/2008
12	Melanoma (Melanoma, Malignant) 01/2022 - 02/2012
11	Brain Neoplasms (Brain Tumor) 05/2021 - 03/2011
10	Oligodendroglioma 01/2017 - 10/2009
8	Sarcoma (Soft Tissue Sarcoma) 01/2016 - 06/2011
5	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2012
4	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 10/2019 - 01/2014
4	Primitive Neuroectodermal Tumors (PNET) 10/2018 - 01/2016
3	Adenoma (Adenomas) 01/2020 - 02/2006
3	Ganglioglioma 10/2018 - 06/2013
3	Cholangiocarcinoma 01/2017 - 07/2014
3	Medulloblastoma 01/2017 - 01/2016
3	Carcinoma (Carcinomatosis) 03/2013 - 06/2011
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2022 - 10/2013
2	Ependymoma 01/2021 - 01/2019
2	Lymphoma (Lymphomas) 05/2020 - 07/2013
2	Carcinogenesis 01/2019 - 07/2014
2	Choroid Plexus Neoplasms (Choroid Plexus Tumor) 01/2019 - 03/2016
2	Necrosis 11/2018 - 04/2009
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2018 - 02/2006
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017 - 08/2010
2	Chondrosarcoma 01/2017 - 04/2014
2	Liver Neoplasms (Liver Cancer) 06/2016 - 07/2014
2	Neurilemmoma (Schwannoma) 01/2016 - 04/2014
2	Neurofibrosarcoma (MPNST) 01/2016 - 04/2014
2	Central Nervous System Cysts (Suprasellar Cyst) 10/2015 - 04/2008
2	Liposarcoma 11/2014 - 04/2014
2	Adenocarcinoma 07/2014 - 10/2013
2	Papillary Thyroid Cancer 05/2014 - 06/2012
2	Solitary Fibrous Tumors 04/2014 - 05/2013
2	Hypoxia (Hypoxemia) 10/2013 - 03/2013
2	Colorectal Neoplasms (Colorectal Cancer) 10/2013 - 02/2012
2	Ovarian Neoplasms (Ovarian Cancer) 09/2013 - 02/2012
2	Meningioma (Meningiomas) 05/2013 - 03/2013
1	Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma) 01/2022
1	Pleomorphic Adenoma 11/2021
1	Triple Negative Breast Neoplasms 10/2021
1	Hydrocephalus (Hydrocephaly) 06/2021
1	Central Nervous System Neoplasms 05/2021
1	Disease Progression 05/2021

Drug/Important Bio-Agent (IBA)

32	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2005
22	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2021 - 10/2009
18	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2010
13	Biomarkers (Surrogate Marker)IBA 05/2020 - 07/2011
12	Biological ProductsIBA 01/2021 - 08/2009
9	Phosphotransferases (Kinase)IBA 01/2020 - 03/2013
9	ParaffinIBA 05/2015 - 11/2009
7	Formaldehyde (Formol)FDA Link 05/2015 - 11/2009
6	Temozolomide (Temodar)FDA LinkGeneric 10/2020 - 07/2015
6	Monoclonal AntibodiesIBA 10/2015 - 01/2010
5	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2019
5	Histones (Histone)IBA 05/2020 - 08/2013
5	Codon (Codons)IBA 01/2017 - 01/2010
5	Messenger RNA (mRNA)IBA 09/2015 - 09/2010
4	Pharmaceutical PreparationsIBA 12/2021 - 04/2009
4	Transcription Factors (Transcription Factor)IBA 01/2019 - 04/2014
3	LY-2157299IBA 10/2020 - 01/2016
3	AntigensIBA 01/2019 - 02/2015
3	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2017 - 08/2009
3	alpha-hydroxyglutarateIBA 01/2017 - 01/2012
3	NestinIBA 06/2016 - 07/2014
3	Mutant Proteins (Protein, Mutant)IBA 03/2013 - 02/2012
2	Reticulin (Reticular Fiber)IBA 01/2022 - 04/2014
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 02/2016
2	Mitogen-Activated Protein KinasesIBA 09/2020 - 03/2013
2	NucleotidesIBA 01/2020 - 01/2016
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2020 - 02/2006
2	ChromatinIBA 01/2019 - 03/2016
2	Bevacizumab (Avastin)FDA Link 01/2018 - 01/2016
2	MethyltransferasesIBA 01/2018 - 01/2018
2	isocitric acid (isocitrate)IBA 01/2018 - 08/2010
2	Lactic Acid (Lactate)FDA LinkGeneric 09/2017 - 07/2005
2	Glial Fibrillary Acidic ProteinIBA 05/2017 - 10/2014
2	Lomustine (CCNU)FDA Link 05/2017 - 01/2016
2	Carmustine (FIVB)FDA Link 02/2016 - 11/2013
2	Alkylating AgentsIBA 02/2016 - 02/2008
2	Neurofibromin 1 (Neurofibromin)IBA 01/2016 - 04/2014
2	ProlactinIBA 01/2016 - 02/2006
2	EpitopesIBA 10/2015 - 02/2015
2	AntibodiesIBA 10/2013 - 07/2005
2	O(6)-Methylguanine-DNA MethyltransferaseIBA 08/2013 - 02/2008
2	Growth Factor ReceptorsIBA 03/2013 - 02/2012
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 03/2012 - 07/2011
2	Angiogenesis InhibitorsIBA 02/2012 - 09/2010
1	Cyclin D1IBA 01/2022
1	somatostatin receptor 2IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Hormones (Hormone)IBA 10/2021
1	gonadotropin releasing hormone associated peptideIBA 05/2021

Therapy/Procedure

33	Therapeutics 01/2022 - 04/2009
8	Drug Therapy (Chemotherapy) 01/2020 - 02/2008
5	Radiotherapy 01/2018 - 02/2012
4	Chemoradiotherapy 01/2021 - 10/2014
4	Ligation 01/2018 - 05/2013
2	Immunotherapy 01/2021 - 02/2015
2	Aftercare (After-Treatment) 12/2017 - 01/2016
1	Ventriculostomy 06/2021